Herpes simplex virus type 1 and Bell's palsya current assessment of the controversy

Journal of NeuroVirology

Volumn 16, Issue 1, 2010, Pages 1-5

  Kennedy, Peter Ge ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Aciclovir; Antiviral agents; Bell's palsy; Herpes simplex virus type 1

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; CORTICOSTEROID; PREDNISOLONE; VALACICLOVIR;

BELL PALSY; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DRUG EFFICACY; FACE PAIN; FACIAL NERVE PARALYSIS; HERPES SIMPLEX VIRUS 1; HUMAN; PRIORITY JOURNAL; SHORT SURVEY;

ADRENAL CORTEX HORMONES; ANIMALS; ANTIVIRAL AGENTS; BELL PALSY; CLINICAL TRIALS AS TOPIC; DRUG THERAPY, COMBINATION; FACIAL PARALYSIS; HERPESVIRUS 1, HUMAN; HUMANS; TREATMENT OUTCOME;

ANIMALIA; HUMAN HERPESVIRUS 1;

EID: 77649305365     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.3109/13550280903552446     Document Type: Short Survey

References (28)

1. Baringer JR (1974). Recovery of herpes simplex virus from human sacral ganglions. N Engl J Med 291: 828-830.
2. Baringer JR, Swoveland P (1973). Recovery of herpes simplex virus from human trigeminal ganglions. N Engl J Med 288: 648-650.
3. Bastian FO, Rabson AS, Yee CL (1972). Herpesvirus hominis: isolation from human trigeminal ganglion. Science 178: 306-307.
4. Davenport RJ, Sullivan F, Smith B, Morrison J, McKinstry B (2008). Treatment for Bell's palsy. Lancet 372: 1219-1220.
5. De Almeida JR, Al Khabori M, Guyatt GH, Witterick IJ, Lin VYW, Nedzelski JM, Chen JM (2009). Combined corticosteroid and antiviral treatment for Bell palsy. A systematic review and meta-analysis. JAMA 302: 985-993.
6. Engstrom M, Berg T, Stjernquist-Desatnik A, Axelsson S, Pitkaranta A, Hultcrantz M, Kanerva M, Hanner P, Jonsson L (2008). Prednisolone and valaciclovir in Bell's palsy: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet (Neurol) 7: 993-1000.
7. Engstrom M, Berg T, Stjernquist-Desatnik A, Axelsson S, Pitkaranta A, Hultcrantz M, Kanerva M, Hanner P, Jonsson L (2009). Is antiviral medication for severe Bell's palsy still useful? Authors' reply. Lancet (Neurol) 8: 509-510.
8. Furuta Y, Takasu T, Sato KC, Fukuda S, Inuyama Y, Nagashima K (1992). Latent herpes simplex virus type 1 in human geniculate ganglia. Acta Neuropathol 84: 39-44.
9. Gilden D (2008). Treatment of Bell's palsy\the pendulum has swung back to steroids alone. Lancet (Neurol) 7: 976-977.
10. Gilden DH, Tyler KL (2007). Bell's palsy\is glucocorticoid treatment enough? N Engl J Med 357: 1653-1655.
11. Gilden DH, Wright RR, Schneck SA, Gwaltney JM Jr, Mahalingam R (1994). Zoster sine herpete, a clinical variant. Ann Neurol 35: 530-533.
12. Hato N, Murakami S, Gyo K (2008). Steroid and antiviral treatment for Bell's palsy. Lancet 371: 1818-1820.
13. Hato N, Yamada H, Kohno H, Matsumoto S, Honda N, Gyo K, Fukuda S, Furuta Y, Ohtani F, Aizawa H, Aoyagi M, Inamura H, Nakashima T, Nakata S, Murakami S, Kiguchi J, Yamano K, Takeda T, Hamada M, Yamakawa K (2007). Valacyclovir and Pred-nisolone treatment for Bell's palsy: a multicenter, randomized, placebo-controlled study. Otol Neurotol 28: 408-413.
14. Kawaguchi K, Inamura H, Abe Y, Koshu H, Takashita E, Muraki Y, Matsuzaki Y, Nishimura H, Ishikawa H, Fukao A, Hongo S, Aoyagi M (2006). Reactivation of herpes simplex virus type-1 and varicella-zoster virus and therapeutic effects of combination therapy with prednisolone and Valacyclovir in patients with Bell's palsy. Laryngoscope 117: 147-156.
15. Kennedy PGE, Al-Saadi SA, Clements GB (1983). Reactivation of latent herpes simplex virus from dissociated identified dorsal root ganglion cells in culture. J Gen Virol 64: 1629-1635.
16. Lockhart P, Daly F, Pitkethly M, Comerford N, Sullivan F (2008). Antiviral treatment for Bell's palsy (idiopathic facial paralysis). Cochrane Database Syst Rev (4): Art. No.: CD001869. DOI: 10.1002/14651858.CD001869.pub4.
17. Mitchell BM, Bloom DC, Cohrs RJ, Gilden DH, Kennedy PGE (2003). Herpes simplex virus-1 and varicella-zoster virus latency in ganglia. J NeuroVirol 9: 194-204.
18. Murakami S, Mizobuchi M, Nakashiro Y, Doi T, Hato N, Yanagihara N (1996). Bell palsy and herpes simplex virus: identification of viral DNA in endoneurial fluid and muscle. Ann Intern Med 124: 27-30.
19. Quant EC, Jeste SS, Muni RH, Cape AV, Bhussar MK, Peleg AY (2009). The benefits of steroids versus steroids plus antivirals for treatment of Bell's palsy: a meta-analysis. BMJ 339: 1-7.
20. Schultz P, Arbusow V, Strupp M, Dieterich M, Rauch E, Brandt T (1998). Highly variable distribution of HSV-1 specific DNA in human geniculate, vestibular and spiral ganglia. Neurosci Lett 14: 139-142.
21. Steiner I, Kennedy PGE (1995). Herpes simplex virus latent infection in the nervous system. J NeuroVirol 1: 19-29.
22. Steiner I, Spivack JG, Lirette RP, Brown SM, MacLean AR, Subak-Sharpe JH, Fraser NW (1989). Herpes simplex virus type 1 latency-associated transcripts are evidently not essential for latent infection. EMBO J 8: 505-511.
23. Sullivan F, Swan I, Daly F (2008). Prednisolone or acyclovir in Bell's palsy. Authors' Reply. N Engl J Med 358: 307.
24. Sullivan FM, Swan IRC, Donnan PT, Morrison JM, Smith BH, McKinstry B, Davenport RJ, Vale LD, Clarkson JE, Hammersley V, Hayavi S, McAteer A, Stewart K, Daly F (2007). Early treatment with prednisolone or acy-clovir in Bell's palsy. New Engl J Med 357: 1598-1606.
25. Thompson RL, Sawtell NM (2001). Herpes simplex virus type 1 latency-associated transcript gene promotes neu-ronal survival. J Virol, 75: 6660-6675.
26. Takasu T, Furuta Y, Sato KC, Fukuda S, Inuyama Y, Nagashima K (1992). Detection of latent herpes simplex virus DNA and RNA in human geniculate ganglia by the polymerase chain reaction. Acta Otolaryngol 112(6): 1004-1011.
27. Wakisaka H, Hato N, Honda N, Takahashi H, Kisaki H, Murakami S, Gyo K, Mominoki K, Kobayashi N, Matsuda S (2002). Demyelination associated with HSV-1-induced facial paralysis. Exp Neurol 178: 68-79.
28. Warren KG, Devlin M, Gilden DH, Wroblewska Z, Koprowski H, Brown SM, Subak-Sharpe J (1978) Herpes simplex virus latency in patients with multiple sclerosis, lymphoma and normal humans. In: Oncogenesis and herpesvirus III, part 2: cell-virus interactions, host response to herpesvirus infection and associated tumors, role of co-factors. de-The G, Henle W, Rapp R (eds). Lyon, France: International Agency for Research on Cancer, pp 765-768.